GlucoTrack, Inc. (GCTK) |
|
0.4954 0.085 (20.83%)
|
03-24 16:00 |
|
Open: |
0.413 |
Pre. Close: |
0.41 |
|
High:
|
0.66 |
Low:
|
0.3715 |
|
Volume:
|
172,922 |
Market Cap:
|
8(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:26:21 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 1.08 One year: 1.5 |
| Support: |
Support1: 0.34 Support2: 0.29 |
| Resistance: |
Resistance1: 0.93 Resistance2: 1.28 |
| Pivot: |
0.54  |
| Moving Average: |
MA(5): 0.43 MA(20): 0.71
MA(100): 1.33 MA(250): 1.97 |
| MACD: |
MACD(12,26): -0.3 Signal(9): -0.3 |
| Stochastic oscillator: |
%K(14,3): 11.1 %D(3): 9.3 |
| RSI: |
RSI(14): 30.2 |
| 52-week: |
High: 4.23 Low: 0.34 |
| Average Vol(K): |
3-Month: 14 (K) 10-Days: 34 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ GCTK ] has closed above bottom band by 43.6%. Bollinger Bands are 111.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 12 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.66 - 0.66 |
0.66 - 0.67 |
|
Low:
|
0.37 - 0.37 |
0.37 - 0.37 |
|
Close:
|
0.49 - 0.5 |
0.5 - 0.5 |
|
Company Description |
|
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel. |
Headline News |
Tue, 14 Mar 2023
GLUCOTRACK PROVIDES SHAREHOLDER UPDATE - GlobeNewswire
Fri, 10 Mar 2023
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are ... - Investing.com UK
Mon, 10 Oct 2022
GLUCOTRACK TO BEGIN RESEARCH & DEVELOPMENT OF NOVEL - GlobeNewswire
Wed, 22 Jun 2022
GlucoTrack, Inc. Provides Development Update on its Gen 2 Non ... - GlobeNewswire
Thu, 17 Mar 2022
Best Stocks Under $5 Right Now • Benzinga - Investing - Benzinga
Mon, 14 Mar 2022
GlucoTrack, Inc. Announces Effectiveness of Corporate Name ... - GlobeNewswire
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. |
16 (M) |
| Shares Float |
10 (M) |
|
% Held by Insiders
|
33.8 (%) |
|
% Held by Institutions
|
0.3 (%) |
|
Shares Short
|
4 (K) |
|
Shares Short P.Month
|
9 (K) |
Stock Financials |
|
EPS
|
-0.26 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0.15 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
-52.2 |
|
Return on Equity (ttm)
|
-105.1 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
-0.01 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
-0.3 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-4 (M) |
|
Levered Free Cash Flow
|
-2 (M) |
Stock Valuations |
|
PE Ratio
|
-1.91 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
3.3 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-2.05 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
